Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 7, Number 9, September 2015, pages 690-693

Minimally Symptomatic Atrial Fibrillation Patients Derive Significant Symptom Relief Following Rate Control or Rhythm Control Therapy

Figure

Figure 1.
Figure 1. Summarization of treatment effect on CCS-SAF score in subpopulations in our low SAF cohort. (a) Our subpopulations of rhythm control (n = 30) and rate control (n=18). (b) Our subpopulations of persistent AF (n = 14) and paroxysmal AF (n = 34).

Table

Table 1. Baseline Demographics for Patients Included in Discussion and Patients Excluded From Discussion
 
Patients included (n = 48)Patients excluded (n = 34)
Comparison between the two groups yielded non-significant (NS) difference in each parameter. *Baseline AF burden available in only 42 patients included in discussion; **Baseline AF burden available in only 28 patients excluded from discussion.
Age (years)71.1 ± 8.8068.2 ± 16.2NS
White93.75% (45)85% (29)NS
Male65% (31)68% (23)NS
BMI30.48 ± 6.2832.13 ± 9.19NS
HTN41.67% (20)44% (15)NS
CHF6.25% (3)12% (4)NS
Beta blocker60.4% (29)68% (23)NS
CCB18.8% (9)24% (8)NS
ACE/ARB29.2% (14)41% (14)NS
Statin35.4% (17)47% (16)NS
Persistent AF29.2% (14)35% (12)NS
Baseline AF burden44.8±46.95%*54.73±48.91%**NS
CHADS2 score1.77 ± 1.361.41 ± 1.10NS
CHADS-VASc score2.85 ± 1.702.44 ± 1.58NS